Fennec Pharmaceuticals (TSE:FRX) Share Price Crosses Below Fifty Day Moving Average – Time to Sell?

Fennec Pharmaceuticals Inc. (TSE:FRX) crossed below its fifty day moving average during trading on Monday . The stock has a fifty day moving average of C$9.40 and traded as low as C$9.21. Fennec Pharmaceuticals shares last traded at C$9.21, with a volume of 201 shares.

Fennec Pharmaceuticals Stock Up 1.8 %

The company has a market cap of C$177.61 million, a P/E ratio of -156.02 and a beta of 0.25. The company has a debt-to-equity ratio of -620.83, a current ratio of 7.80 and a quick ratio of 10.17. The business’s 50 day moving average price is C$9.40 and its 200-day moving average price is C$8.09.

Insider Activity

In related news, Director Rostislav Christov Raykov sold 10,000 shares of the stock in a transaction that occurred on Monday, January 6th. The shares were sold at an average price of C$8.76, for a total value of C$87,552.00. Insiders have sold 21,186 shares of company stock valued at $196,017 over the last 90 days. 16.20% of the stock is owned by company insiders.

About Fennec Pharmaceuticals

Fennec Pharmaceuticals Inc operates as a biopharmaceutical company in the United States. The company's product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. It sells its products through regional pediatric oncology specialists and medical science liaisons.